Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1976 4
1977 3
1978 2
1979 15
1980 6
1981 1
1982 10
1983 10
1984 4
1985 11
1986 5
1987 13
1988 9
1989 15
1990 19
1991 14
1992 29
1993 22
1994 20
1995 20
1996 22
1997 11
1998 11
1999 15
2000 14
2001 20
2002 17
2003 17
2004 7
2005 9
2006 12
2007 20
2008 24
2009 15
2010 16
2011 21
2012 29
2013 50
2014 39
2015 36
2016 47
2017 54
2018 65
2019 51
2020 44
2021 47
2022 56
2023 71
2024 39

Text availability

Article attribute

Article type

Publication date

Search Results

926 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 and mucormycosis superinfection: the perfect storm.
Al-Tawfiq JA, Alhumaid S, Alshukairi AN, Temsah MH, Barry M, Al Mutair A, Rabaan AA, Al-Omari A, Tirupathi R, AlQahtani M, AlBahrani S, Dhama K. Al-Tawfiq JA, et al. Infection. 2021 Oct;49(5):833-853. doi: 10.1007/s15010-021-01670-1. Epub 2021 Jul 24. Infection. 2021. PMID: 34302291 Free PMC article. Review.
PURPOSE: In this review, we included most recent reported case reports and case-series of mucormycosis among patients with COVID-19 and describe the clinical features and outcome. RESULTS: Many of the mucormycosis reports were eported from India, especially in COVID-19 pat …
PURPOSE: In this review, we included most recent reported case reports and case-series of mucormycosis among patients with COVID-19 and desc …
AmpC β-lactamase-producing Enterobacterales: what a clinician should know.
Meini S, Tascini C, Cei M, Sozio E, Rossolini GM. Meini S, et al. Infection. 2019 Jun;47(3):363-375. doi: 10.1007/s15010-019-01291-9. Epub 2019 Mar 6. Infection. 2019. PMID: 30840201 Review.
Carbapenems are often the preferred option, especially for severe infections in which adequate source control is not achieved, but cefepime is also supported by substantial clinical evidences as an effective carbapenem-sparing option....
Carbapenems are often the preferred option, especially for severe infections in which adequate source control is not achieved, but cefepime …
Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab.
Franceschini E, Pellegrino M, Todisco V, Dolci G, Bettelli F, Meschiari M, Bedini A, Fregni-Serpini G, Grottola A, Guaraldi G, Pecorari M, Sarti M, Luppi M, Perno CF, Mussini C. Franceschini E, et al. Infection. 2023 Oct;51(5):1577-1581. doi: 10.1007/s15010-023-02039-2. Epub 2023 Apr 19. Infection. 2023. PMID: 37076752 Free PMC article.
Intestinal barrier dysfunction in HIV infection: pathophysiology, clinical implications and potential therapies.
Assimakopoulos SF, Dimitropoulou D, Marangos M, Gogos CA. Assimakopoulos SF, et al. Infection. 2014 Dec;42(6):951-9. doi: 10.1007/s15010-014-0666-5. Epub 2014 Jul 29. Infection. 2014. PMID: 25070877 Review.
METHODS: Review of the literature on the role of intestinal barrier dysfunction in HIV infection, with emphasis on the implicated pathophysiological mechanisms, clinical implications and potentially effective therapeutic interventions. ...
METHODS: Review of the literature on the role of intestinal barrier dysfunction in HIV infection, with emphasis on the implicated pathophysi …
Species distribution and clinical features of infection and colonisation with non-tuberculous mycobacteria in a tertiary care centre, central Germany, 2006-2016.
Wetzstein N, Hügel C, Wichelhaus TA, Hogardt M, Eickmeier O, Küpper-Tetzel CP, Kann G, Just-Nübling G, Stephan C, Wolf T. Wetzstein N, et al. Infection. 2019 Oct;47(5):817-825. doi: 10.1007/s15010-019-01317-2. Epub 2019 May 15. Infection. 2019. PMID: 31093923
Patient data were retrieved using the local patient data management system. Different groups were formed according to clinical manifestations, underlying diseases and mycobacterial species. ...But mortality analysis showed non-significant results within different mycobacte …
Patient data were retrieved using the local patient data management system. Different groups were formed according to clinical manife …
Helicobacter pylori and oral-gut microbiome: clinical implications.
Elghannam MT, Hassanien MH, Ameen YA, Turky EA, ELattar GM, ELRay AA, ELTalkawy MD. Elghannam MT, et al. Infection. 2024 Apr;52(2):289-300. doi: 10.1007/s15010-023-02115-7. Epub 2023 Nov 2. Infection. 2024. PMID: 37917397 Free PMC article. Review.
Infection with Nocardia species: clinical spectrum of disease and species distribution in Madrid, Spain, 1978-2001.
Pintado V, Gómez-Mampaso E, Fortún J, Meseguer MA, Cobo J, Navas E, Quereda C, Martín-Dávila P, Moreno S. Pintado V, et al. Infection. 2002 Dec;30(6):338-40. doi: 10.1007/s15010-002-2127-9. Infection. 2002. PMID: 12478321
BACKGROUND: Clinical experience with nocardiosis is very limited in European countries. ...Most isolates were initially identified as Nocardia asteroides complex (97%). The most common clinical form was pulmonary disease (41%), followed by disseminated (15%), cutane …
BACKGROUND: Clinical experience with nocardiosis is very limited in European countries. ...Most isolates were initially identified as …
Evaluation and management of Staphylococcus aureus bacteriuria: an updated review.
Karakonstantis S, Kalemaki D. Karakonstantis S, et al. Infection. 2018 Jun;46(3):293-301. doi: 10.1007/s15010-017-1100-6. Epub 2017 Nov 11. Infection. 2018. PMID: 29129031 Review.
SABU may also serve as the focus for subsequent bacteremia and invasive infections. We did not find any clinical trials regarding the management of patients with SABU. CONCLUSIONS: Based on our review, we suggest an algorithmic approach for the evaluation and management of …
SABU may also serve as the focus for subsequent bacteremia and invasive infections. We did not find any clinical trials regarding the …
Neonatal invasive disease caused by Streptococcus agalactiae in Europe: the DEVANI multi-center study.
Lohrmann F, Hufnagel M, Kunze M, Afshar B, Creti R, Detcheva A, Kozakova J, Rodriguez-Granger J, Sørensen UBS, Margarit I, Maione D, Rinaudo D, Orefici G, Telford J, de la Rosa Fraile M, Kilian M, Efstratiou A, Berner R, Melin P; DEVANI Study Group. Lohrmann F, et al. Infection. 2023 Aug;51(4):981-991. doi: 10.1007/s15010-022-01965-x. Epub 2022 Dec 22. Infection. 2023. PMID: 36547864 Free PMC article.
This study, a major component of the European DEVANI project (Design of a Vaccine Against Neonatal Infections) describes clinical and important microbiological characteristics of neonatal GBS diseases. ...RESULTS: Respiratory distress was the most frequent clinical …
This study, a major component of the European DEVANI project (Design of a Vaccine Against Neonatal Infections) describes clinical and …
Evaluation and clinical practice of pathogens and antimicrobial resistance genes of BioFire FilmArray Pneumonia panel in lower respiratory tract infections.
Gong J, Yang J, Liu L, Chen X, Yang G, He Y, Sun R. Gong J, et al. Infection. 2024 Apr;52(2):545-555. doi: 10.1007/s15010-023-02144-2. Epub 2023 Dec 20. Infection. 2024. PMID: 38123753 Free PMC article.
METHODS: The bronchoalveolar lavage fluid of 187 patients with LRTIs was simultaneously analyzed using a PN panel and cultivation, and the impact of the PN panel on clinical practice was assessed. The primary endpoint was to compare the consistency between the PN panel and …
METHODS: The bronchoalveolar lavage fluid of 187 patients with LRTIs was simultaneously analyzed using a PN panel and cultivation, and the i …
926 results